Highland Capital Management LLC Sells 430 Shares of Envista Holdings Co. (NYSE:NVST)

Highland Capital Management LLC reduced its stake in Envista Holdings Co. (NYSE:NVSTGet Rating) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,860 shares of the company’s stock after selling 430 shares during the period. Highland Capital Management LLC owned 0.06% of Envista worth $3,656,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of NVST. CI Investments Inc. increased its stake in shares of Envista by 8,922.2% during the first quarter. CI Investments Inc. now owns 812 shares of the company’s stock valued at $40,000 after purchasing an additional 803 shares in the last quarter. Covestor Ltd increased its stake in shares of Envista by 35.0% during the first quarter. Covestor Ltd now owns 1,273 shares of the company’s stock valued at $62,000 after purchasing an additional 330 shares in the last quarter. Elequin Capital LP bought a new position in shares of Envista during the first quarter valued at approximately $64,000. Parkside Financial Bank & Trust increased its stake in shares of Envista by 32.7% during the first quarter. Parkside Financial Bank & Trust now owns 2,481 shares of the company’s stock valued at $121,000 after purchasing an additional 612 shares in the last quarter. Finally, Wakefield Asset Management LLLP bought a new position in shares of Envista during the first quarter valued at approximately $231,000.

Envista Trading Up 0.8 %

Shares of NVST stock opened at $33.77 on Friday. Envista Holdings Co. has a 12-month low of $32.86 and a 12-month high of $52.03. The company has a current ratio of 1.11, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The firm’s 50 day moving average is $38.26 and its 200 day moving average is $41.30. The stock has a market capitalization of $5.52 billion, a P/E ratio of 20.10, a P/E/G ratio of 1.33 and a beta of 1.54.

Envista (NYSE:NVSTGet Rating) last issued its earnings results on Wednesday, August 3rd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. Envista had a net margin of 11.86% and a return on equity of 8.26%. The company had revenue of $645.80 million for the quarter, compared to analysts’ expectations of $657.55 million. Research analysts expect that Envista Holdings Co. will post 1.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on NVST shares. Robert W. Baird downgraded shares of Envista from an “outperform” rating to a “neutral” rating and decreased their target price for the company from $54.00 to $46.00 in a research note on Tuesday, June 14th. TheStreet downgraded shares of Envista from a “b” rating to a “c+” rating in a research report on Friday, June 17th. Evercore ISI reduced their price target on shares of Envista to $44.00 in a research report on Tuesday, August 9th. The Goldman Sachs Group reduced their price target on shares of Envista from $58.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, July 21st. Finally, Stifel Nicolaus reduced their price target on shares of Envista from $55.00 to $50.00 in a research report on Friday, June 17th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $46.86.

Envista Company Profile

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.

Read More

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTGet Rating).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.